Molecular Docking Studies of Bioactive Compounds from Solenostemma Argel Leaf Extract as Potential Inhibitor for BCL-2 Antiapoptotic Proteins

Mehad Mustafa Adam Khamiss; Prakash C. Choudhary1

1

Publication Date: 2020/10/09

Abstract: This article deals with anticancer studies of phytochemicals identified from Solenostemma Argel leaf extract using GC-MS analysis and molecular docking studies. B cell lymphoma-2 (BCL-2) agonists are useful for regulating apoptosis which is essential for several cancers. The aim of the present study is to investigate the BCl-2 agonist property of phytochemicals from the extract of S. Argel using an Insilco approach. The docking on human BCL-2 protein was determined by GOLD 3.0.1 software. It is concluded from the studies that compound suggested by GCMS at RT 17.1 minute is 4,5,7-trihydroxy isoflavone showed best result with highest fitness index

Keywords: Cancer; Docking studies; BCL-2; Solenostemma argel

DOI: 10.38124/IJISRT20SEP781

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT20SEP781.pdf

REFERENCES

No References Available